Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential insights into new therapeutic approaches. Current focus centers on targeting the underlying pathophysiology of MSA. One strategy under investigation involves drug-based interventions to influence the activity